Drug profile · INN
ethacrynic acid
ETHACRYNIC ACID
ethacrynic acid (ETHACRYNIC ACID) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — ethacrynic acid
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
ethacrynic acid (ETHACRYNIC ACID) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Sodium-(potassium)-chloride cotransporter 2 inhibitor
Primary target: Solute carrier family 12 member 1
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ethacrynic acid?
ethacrynic acid (ETHACRYNIC ACID) is a sodium-(potassium)-chloride cotransporter 2 inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ethacrynic acid?
ETHACRYNIC ACID is a marketed brand name for ethacrynic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ethacrynic acid?
ethacrynic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.